Trius Therapeutics TSRX Stock Research Page
"Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections"
Lead program: tedezolid for acute bacterial skin and skin structure infections (ABSSSI) - click here for more information.
For more detailed coverage, contact Jason Napadano of Zacks @JNapadano
TSRX - archive of related blog posts and articles
3/2012 Citi Healthcare conference - click for my notes.